CGNX CGNX
Company Profile ↓Company Overview
CGNX (CGNX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Operating margin of 16.4% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $994.36M (+8.7% YoY); net profit $114.44M.
- Trailing 12 Months Year-on-year growth — revenue +8.7%, earnings +7.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.6%, profit CAGR 8.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.65% |
| 1 Year: | 8.73% |
Compounded Profit Growth
| 5 Years: | 8.80% |
| 1 Year: | 7.79% |
Stock Price Performance
| 1 Year: | +71.85% |
| 6 Months: | +73.59% |
| 3 Months: | +20.36% |
| 1 Month: | +10.12% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)62.30 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 104.0.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2014 | Sep 2014 | Apr 2015 | Jul 2015 | Oct 2015 | Apr 2016 | Jul 2016 | Oct 2016 | Apr 2017 | Jul 2017 | Oct 2017 | Dec 2017 | Apr 2018 | Jul 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Oct 2022 | Apr 2023 | Jul 2023 | Oct 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 169.57M | 211.26M | 232.22M | 193.29M | 173.48M | 199.05M | 183.32M | 169.77M | 173.48M | 199.05M | 183.32M | 169.77M | 167.24M | 169.10M | 251.07M | 223.62M | 239.03M | 269.16M | 284.85M | 282.41M | 274.63M | 209.62M | 201.12M | 242.51M | 197.24M | 210.80M | 239.29M | 234.74M | 216.04M | 249.09M | 276.89M | 268.44M |
| Gross Profit | 74.09M | 116.64M | 79.03M | 113.32M | 81.27M | 75.24M | 112.06M | 115.20M | 129.37M | 157.09M | 173.36M | 140.46M | 127.20M | 148.08M | 135.69M | 124.90M | 127.20M | 148.08M | 135.69M | 124.90M | 126.03M | 118.78M | 191.33M | 168.46M | 184.98M | 200.73M | 199.14M | 203.62M | 196.49M | 152.24M | 143.74M | 179.68M | 142.77M | 141.94M | 166.60M | 159.40M | 144.32M | 167.88M | 187.29M | 190.94M |
| Operating Income | 26.02M | 55.34M | 22.11M | 51.78M | 28.48M | 16.34M | 49.67M | 54.53M | 34.60M | 63.45M | 77.84M | 45.25M | 30.15M | 51.76M | 43.09M | 17.61M | 30.15M | 51.76M | 43.09M | 17.61M | 20.95M | -6.14M | 96.64M | 59.09M | 78.45M | 92.58M | 87.55M | 86.73M | 65.14M | 40.02M | 22.16M | 65.17M | 30.64M | 14.20M | 38.46M | 31.56M | 26.09M | 43.43M | 57.77M | 59.87M |
| Net Income | 25.95M | 50.40M | 20.50M | 43.71M | 104.11M | 14.88M | 42.76M | 53.67M | 37.22M | 56.20M | 80.44M | 45.42M | 33.10M | 48.75M | 41.69M | 80.33M | 33.10M | 48.75M | 41.69M | 80.33M | 20.48M | -1.14M | 87.51M | 69.34M | 69.85M | 77.60M | 78.90M | 67.33M | 58.90M | 33.98M | 25.61M | 57.47M | 18.92M | 12.02M | 36.21M | 29.59M | 23.60M | 40.51M | 17.66M | 51.70M |
| Diluted EPS | 0.29 | 0.57 | 0.23 | 0.49 | 1.19 | 0.17 | 0.49 | 0.61 | 0.21 | 0.32 | 0.45 | 0.26 | 0.19 | 0.28 | 0.24 | 0.46 | 0.19 | 0.28 | 0.24 | 0.46 | 0.12 | -0.01 | 0.49 | 0.39 | 0.39 | 0.43 | 0.44 | 0.38 | 0.34 | 0.19 | 0.15 | 0.33 | 0.11 | 0.07 | 0.21 | 0.17 | 0.14 | 0.24 | 0.10 | 0.31 |
| R&D Expense | 12.52M | 17.53M | 16.99M | 18.30M | 16.98M | 20.55M | 19.67M | 18.60M | 22.77M | 23.38M | 26.08M | - | 31.08M | 26.89M | 29.70M | - | 30.24M | 28.08M | 28.11M | - | 35.95M | 30.40M | 30.24M | - | 34.10M | 31.30M | 34.48M | 36.05M | 33.99M | 33.95M | 38.54M | 33.59M | 32.58M | 37.10M | 34.96M | 35.21M | 34.73M | 33.10M | 35.08M | 37.02M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 242.68M | 175.73M | 290.69M | 321.91M | 324.28M | 307.65M | 426.45M | 450.56M | 529.51M | 766.08M | 806.34M | 725.62M | 811.02M | 1.04B | 1.01B | 837.55M | 914.51M | 994.36M |
| Gross Profit | 174.25M | 119.34M | 213.10M | 244.00M | 244.78M | 244.76M | 332.38M | 347.99M | 398.44M | 578.79M | 600.29M | 535.87M | 604.60M | 759.83M | 721.90M | 601.24M | 625.79M | 665.39M |
| Operating Income | 25.10M | -12.67M | 75.71M | 85.36M | 83.41M | 76.94M | 127.85M | 121.52M | 154.07M | 258.86M | 221.14M | 142.60M | 170.53M | 315.10M | 246.23M | 130.70M | 115.06M | 162.57M |
| Net Income | 27.27M | -4.87M | 61.38M | 69.87M | 68.10M | 73.57M | 121.48M | 187.07M | 143.69M | 176.71M | 219.27M | 203.87M | 176.19M | 279.88M | 215.53M | 113.23M | 106.17M | 114.44M |
| Diluted EPS | 0.66 | -0.12 | 1.52 | 0.82 | 0.78 | 0.83 | 1.36 | 1.06 | 0.83 | 0.98 | 1.24 | 1.16 | 1.00 | 1.56 | 1.23 | 0.65 | 0.62 | 0.68 |
| R&D Expense | 36.26M | 31.13M | 33.08M | 40.95M | 41.55M | 44.31M | 55.83M | 69.79M | 78.27M | 99.20M | 116.44M | 119.43M | 130.98M | 135.37M | 141.13M | 139.40M | 139.81M | 138.97M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 439.87M | 533.10M | 611.88M | 627.61M | 709.70M | 821.73M | 887.76M | 1.04B | 1.29B | 1.29B | 1.89B | 1.80B | 2.00B | 1.96B | 2.02B | 1.99B | 2.02B |
| Total Equity | 476.37M | 413.07M | 394.45M | 473.31M | 552.98M | 572.28M | 643.91M | 736.44M | 832.33M | 963.38M | 1.10B | 1.14B | 1.36B | 1.26B | 1.43B | 1.44B | 1.50B | 1.52B | 1.49B |
| Cash & Equivalents | 104.14M | 127.14M | 119.83M | 33.20M | 38.10M | 45.16M | 40.64M | 55.69M | 51.98M | 79.64M | 106.58M | 108.21M | 171.43M | 269.07M | 186.16M | 181.37M | 202.66M | 186.09M | 262.93M |
| Total Liabilities | - | - | - | - | - | - | - | 85.30M | 62.09M | 76.00M | 192.08M | 154.40M | 530.23M | 538.50M | 573.57M | 519.75M | 513.06M | 475.35M | 524.65M |
| Current Liabilities | - | - | 38.68M | 54.43M | 54.10M | 50.10M | 61.02M | 80.67M | 53.69M | 65.77M | 112.64M | 91.36M | 120.48M | 132.30M | 188.59M | 187.71M | 151.88M | 169.38M | 183.55M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 58.94M | 12.28M | 76.33M | 86.28M | 101.13M | 95.45M | 163.84M | 128.33M | 182.08M | 224.32M | 223.45M | 253.31M | 242.40M | 314.06M | 243.41M | 112.92M | 149.08M | 245.51M |
| Investing Cash Flow | 64.54M | -466.00K | -176.48M | -90.21M | -38.85M | -88.07M | -104.10M | -10.55M | -121.83M | -105.56M | -10.83M | -157.34M | 169.44M | -252.54M | -4.45M | 32.27M | -38.97M | 28.02M |
| Financing Cash Flow | -95.53M | -21.30M | 20.23M | 9.79M | -45.15M | -12.46M | -42.74M | -116.83M | -29.23M | -100.12M | -209.90M | -32.23M | -316.87M | -141.62M | -240.37M | -125.61M | -118.42M | -206.69M |
| Capital Expenditure | -6.01M | -5.47M | -5.85M | -7.82M | -9.88M | -9.63M | -20.93M | -18.23M | -12.82M | -28.75M | -37.09M | -21.75M | -13.30M | -15.46M | -19.67M | -23.08M | -15.04M | -8.74M |
| Free Cash Flow | 52.92M | 6.82M | 70.48M | 78.45M | 91.25M | 85.83M | 142.91M | 110.10M | 169.26M | 195.57M | 186.36M | 231.57M | 229.10M | 298.61M | 223.74M | 89.84M | 134.04M | 236.77M |
| Share Buybacks | 92.97M | - | - | 10.00M | 0 | 47.91M | 59.67M | 126.35M | 47.15M | 123.72M | 203.82M | 61.69M | 51.04M | 161.65M | 204.31M | 79.79M | 67.08M | 151.23M |
| Dividends Paid | - | - | - | - | - | - | - | 18.06M | 25.21M | 29.04M | 31.86M | 35.12M | 390.51M | 43.26M | 45.92M | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 71.8% | 67.9% | 73.3% | 75.8% | 75.5% | 79.6% | 77.9% | 77.2% | 75.2% | 75.6% | 74.4% | 73.8% | 74.5% | 73.3% | 71.8% | 71.8% | 68.4% | 66.9% |
| Operating Margin % | 10.3% | -7.2% | 26.0% | 26.5% | 25.7% | 25.0% | 30.0% | 27.0% | 29.1% | 33.8% | 27.4% | 19.7% | 21.0% | 30.4% | 24.5% | 15.6% | 12.6% | 16.3% |
| Net Margin % | 11.2% | -2.8% | 21.1% | 21.7% | 21.0% | 23.9% | 28.5% | 41.5% | 27.1% | 23.1% | 27.2% | 28.1% | 21.7% | 27.0% | 21.4% | 13.5% | 11.6% | 11.5% |
| ROE % | 6.6% | -1.2% | 13.0% | 12.6% | 11.9% | 11.4% | 16.5% | 22.5% | 14.9% | 16.1% | 19.3% | 15.0% | 14.0% | 19.6% | 15.0% | 7.5% | 7.0% | 7.7% |
| ROCE % | - | -3.2% | 15.8% | 15.3% | 14.4% | 11.9% | 17.3% | 14.6% | 15.8% | 22.0% | 18.5% | 8.1% | 10.2% | 17.4% | 13.9% | 7.0% | 6.3% | 8.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CGNX
Hundreds of customers use Cognex’s OneVision platform for AI-powered vision applications - Stock Titan
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPRlBOdmp2WTZJS1V5RDBTTDdvVmZ4eWp4eHFqd1VwWFdIRThZOVFGelBwa0gzdi1sbUltcjFobGVsN3Q5UEJadXRZVzVPaGZXbzY2OW5keWdiUVVXOTl3ZjBmcmRiS1laRS1qbG5Obmg4OElmVTQ3cTRLc3NKbWV0Zkl2Rm5qWHg2dFBySl…
Cognex (CGNX) Stock Looks Overvalued On Cash Flow And Earnings - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQaEJhY3FnanhITUpRcHNSY3pmb1Y3RFpvWG5IN0hYcnhUX183ZllKeVFRRW1JODZGODNKUFpXeHR0eE93VGl3Y29vQ25xM3phMXMxYTNMOXJBYkNvcHN1THJ3TlZ1bzRzUk9jNk5RNTlPYmJTa3NfdUtiREdkWHV6REVRLWlnM3JsT3ZMd2…
Cognex Corp (CGNX) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 81/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOTjA4UnQwX3g3QXNSWXQ0cWFKMU9obHFHOGw3bi1sZE13NnFlb05QOHRGWXpQZXlrRXNTVlozMmhsaGx1Qlo1b1lKenViNXF0bkgxSzR5WlZEelRxSDhTTTd2LW1fa1dFNy04ZDJkNEgtS1dZN0x3MVE3RXlZQ205YUE0NEo0WFZpQUJobE…
Cognex (CGNX) Stock Looks Strong On Earnings But Overvalued On Cash Flow - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBESFNQeElFU3ByaTJSLXdvUVZXajMwMW1MTWdBa2hDUnotU1dleGRNZDJNbWJrOXRnNEc1a2pkVG84SmxlYlprUzRfb29YM0taVy1YYTZFSm4?oc=5" target="_blank">Cognex (CGNX) Stock Looks Strong On Earnings But…
Cognex (CGNX) Q2 Earnings Report Preview: What To Look For - StockStory
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOd3hXa0ZhWmFCeWZ1anFOT0NKRUoyYjk5VjBmRTBsaG42Z25KZ2xRd2I1a3diWXRMWkJQOFFrU2NSM2gxUXMyc3dWR1FhRWluQUFPR0RXVkdGVUh5aHRMUi1iQmtqYVZkQjUzWXpoN3lDaDhwNXFJUUJwOWdpdllzY0FDaE5NRnZNNUhvWk…
Cognex (NASDAQ:CGNX) Misses Q2 CY2026 Revenue Estimates - FinancialContent
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQM05ZZkFlSC16dGlvc1N1M1A3TG82bHpHVTFzdEliUFBpY3ZDWVBPeTZ1cExXdkxSR2xTYWxWekhxbXcyYVJlSXdsT3h2SXBuQ2hxVEpxTzVYZ2RjR3l5RDFPQjFpUVpYQXJEX1dNSnRzWDdfS0FHLTJHdlZaR09pT0s0QWFENnNCLUlibH…
CGNX — Frequently Asked Questions
What is the current share price of CGNX?
As of 2026-08-05 17:25 PDT, CGNX trades at $70.71 on NASDAQ/NYSE. Its 52-week range is $34.70 to $72.42.
What is the P/E ratio of CGNX?
CGNX trades at a trailing price-to-earnings (P/E) ratio of 103.99.
What is the return on equity (ROE) of CGNX?
CGNX has a return on equity (ROE) of 7.67%. Its return on capital employed (ROCE) is 8.87%.
Is CGNX a good stock to buy?
This page provides a data-driven analysis of CGNX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.